study	individual	group	count	intervention	time	time_unit	method	x_measurement_type	x_substance	x_tissue	x_label	x_value	x	x_unit	y_measurement_type	y_substance	y_tissue	y_label	y	y_value	y_unit	comments
Donzelli2014	cyp1a2_1_1_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1_1	0.828627082245788	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1_1	NA	0.5707656612529	ng/ml*hr	NA
Donzelli2014	cyp1a2_1_1f_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1_1f	0.708489788093938	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1_1f	NA	0.500046403712297	ng/ml*hr	NA
Donzelli2014	cyp1a2_1_1f_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1_1f	0.879174333946716	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1_1f	NA	0.539025522041763	ng/ml*hr	NA
Donzelli2014	cyp1a2_1_1f_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1_1f	0.978826820997164	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1_1f	NA	0.609744779582366	ng/ml*hr	NA
Donzelli2014	cyp1a2_1_1f_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1_1f	0.959007730519431	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1_1f	NA	0.639814385150812	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	0.498918963021992	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.399814385150812	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	0.539194026611237	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.420417633410672	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	0.649095254353022	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.48	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	0.799265525400448	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.5707656612529	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	0.919460487532071	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.54013921113689	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	0.90848360938182	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.630904872389791	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	0.949464630437762	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.610858468677494	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S8	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	1.11878288876971	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.650951276102088	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S9	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	1.14811624533923	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.700510440835267	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S10	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	1.33915980605181	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.960556844547564	ng/ml*hr	NA
Donzelli2014	cyp1a2_1f_1f_S11	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	px/caf	plasma	paraxanthine_caffeine_ratio_1f_1f	1.46893684168	NA	ng/ml	auc_ratio	px/caf	plasma	paraxanthine_caffeine_auc_ratio_1f_1f	NA	0.890394431554524	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	30.0066755674232	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	26.3375486734884	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	30.9078771695594	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	24.0514515421651	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	31.5086782376501	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	25.7578768060983	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	33.6448598130841	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	20.0969956311985	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	36.5153538050734	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	32.9121466250221	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	36.8491321762349	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	34.6546756837307	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	39.886515353805	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	34.7294759618995	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S8	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	43.3911882510013	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	39.2692252707179	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S9	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	49.2323097463284	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	43.3388014024749	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_1_S10	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_1	90.754339118825	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_1	NA	61.626657685141	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_6_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_6	25.1001335113484	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_6	NA	20.6352571729032	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_6_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_6	34.1455273698264	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_6	NA	27.2479943009312	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_6_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_6	35.2469959946595	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_6	NA	32.548249450568	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_6_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_6	37.6168224299065	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_6	NA	31.715124097708	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_6_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_6	42.2897196261682	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_6	NA	33.8237795584675	ng/ml*hr	NA
Donzelli2014	cyp2b6_1_6_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_ratio_1_6	57.8437917222964	NA	ng/ml	auc_ratio	efavirenz/8-hydroxyefavirenz	plasma	efavirenz_8_OH_efavirenz_auc_ratio_1_6	NA	44.6517679955609	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.0444290177021867	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.191125766516256	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.0510933703575147	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.10136228825937	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.0538701839639014	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.0980642493267029	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.0565081568899687	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.148561475376972	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.0633113502256161	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.104012633127248	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.072058313085734	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.147254173525648	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.0774730996181881	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.18554246955414	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S8	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.0781673030197848	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.154849973022293	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S9	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.123845886844845	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.190861258982545	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S10	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_1	0.17910447761194	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_1	NA	0.30311807300133	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_2_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_2	0.111072544255466	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_2	NA	0.181939828831893	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_2_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_2	0.152724748351266	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_2	NA	0.189564954412831	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_3	0.104408191600138	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_3	NA	0.207016838441914	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_3	0.148281846581048	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_3	NA	0.189561288652294	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_3	0.198403332176327	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_3	NA	0.588612544003445	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	losartan/exp3174	plasma	losartan_exp3174_ratio_1_3	0.226032627559875	NA	ng/ml	auc_ratio	losartan/exp3174	plasma	losartan_exp3174_auc_ratio_1_3	NA	0.331869663884125	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_1_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_1	0.501958029745783	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.511651741696631	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_1_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_1	0.667385759540099	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.565105639025599	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_1_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_1	1.13343218573836	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.915152259550025	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_1_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_1	1.33881621474267	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.933491387429066	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_1_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_1	1.41878562612647	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.986915264271472	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_1_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_1	2.29698621753006	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	1.39050245417477	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_1_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_1	3.59183888230823	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	2.63732734386966	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_2_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_2	2.30438158685386	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	2.48652378744268	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	0.500515109585267	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.371136012333577	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	0.526816929423934	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.617046891193005	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	0.570843102769002	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.440013176733993	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	0.664593531488989	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.487821285783895	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	0.719759564954729	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.556693123968953	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	0.943112630570959	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.684640437692237	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	1.26163322099322	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	0.944705491763814	ng/ml*hr	NA
Donzelli2014	cyp2c19_1_17_S8	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	ome/5home	plasma	omeprazole_5_OH_omeprazole_ratio_1_17	1.50019472966148	NA	ng/ml	auc_ratio	ome/5home	plasma	omeprazole_5_OH_omeprazole_auc_ratio	NA	1.17382910821885	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	1.89775051124744	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	2.0111111111111	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	2.99795501022495	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	2.4	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	3.79550102249488	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.00555555555555	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	3.90184049079754	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	2.7	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	3.9959100204499	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.30555555555555	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	4.29447852760736	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	2.81111111111111	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	4.39672801635991	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.4	ng/ml*hr	NA
Donzelli2014	cyp2d6_11_12_22_S8	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	6.99795501022495	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	5.10555555555555	ng/ml*hr	NA
Donzelli2014	cyp2d6_14_29_241_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	3.19836400817995	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.0	ng/ml*hr	NA
Donzelli2014	cyp2d6_14_29_241_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	3.29243353783231	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	2.19999999999999	ng/ml*hr	NA
Donzelli2014	cyp2d6_14_29_241_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	4.59713701431492	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.4	ng/ml*hr	NA
Donzelli2014	cyp2d6_14_29_241_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	4.79345603271983	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.4	ng/ml*hr	NA
Donzelli2014	cyp2d6_14_29_241_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	4.88752556237218	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.4	ng/ml*hr	NA
Donzelli2014	cyp2d6_14_29_241_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	4.98977505112474	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	3.69999999999999	ng/ml*hr	NA
Donzelli2014	cyp2d6_4_41_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_ratio	8.40081799591002	NA	ng/ml	auc_ratio	metoprolol/alpha-hydroxymetoprolol	plasma	metoprolol_OH_metoprolol_auc_ratio	NA	10.3111111111111	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	1.14902323452858	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	1.40508547293754	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	1.16958822351673	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	1.29362266057757	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	1.48973657364592	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	1.499995232965	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	1.94923012384756	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	2.40034799355496	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	2.32678692306958	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	2.80182386759083	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	2.39045544252385	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	2.69874150276011	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	2.47071610399763	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	2.09682801491128	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S8	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	2.54844356307263	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	2.89946513867304	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S9	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	2.61628228474453	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	2.60688169172538	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S10	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	2.87875427841391	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	3.40124419613488	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S11	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	3.24621926454184	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	3.3010897442009	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S12	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	3.96424819091021	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	4.50253796943377	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S13	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	4.22271492177295	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	5.00428365765061	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1_S14	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	4.29455890625149	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	5.00431702689561	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_1b_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	0.896647820988301	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	1.09841925119414	ng/ml*hr	NA
Donzelli2014	cyp3a4_1_2_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	2.0	h	HPLC MS/MS	concentration	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_ratio	1.36852326789783	NA	ng/ml	auc_ratio	midazolam/1-hydroxymidazolam	plasma	midazolam_1_OH_midazolame_auc_ratio	NA	1.80648793463441	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	22.5078125	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	5.23215691022459	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	19.5720108695652	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	9.86560206140136	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	18.5631443298969	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	10.1973961649212	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	17.6965601965602	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	6.73122017307999	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S5	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	15.7949561403509	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	9.61421675361886	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S6	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	13.8776493256262	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	6.79097899949046	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S7	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	12.90770609319	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	5.3896016497086	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S8	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	12.7930728241563	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	6.45786357260802	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S9	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	8.07455156950676	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	5.2394079622594	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_1_S10	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_1	5.58333333333334	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_1	NA	3.29904446177847	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_2_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_2	9.00312500000007	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_2	NA	5.49632263820568	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_2_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_2	6.54772727272731	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_2	NA	5.27523667598505	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S1	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_3	9.57779255319157	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_3	NA	4.83052493471726	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S2	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_3	6.74391385767791	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_3	NA	5.27533868918916	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S3	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_3	5.04023792862143	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_3	NA	1.69891044658767	ng/ml*hr	NA
Donzelli2014	cyp2c9_1_3_S4	NA	1.0	LOS12.5, OME10, MID2, CAF100, MET12.5, EFA50	8.0	h	HPLC MS/MS	concentration	exp3174/losartan	plasma	exp3174_losartan_ratio_1_3	4.42414004914005	NA	ng/ml	auc_ratio	exp3174/losartan	plasma	exp3174_losartan_auc_ratio_1_3	NA	3.01323112301448	ng/ml*hr	NA
